Evidence map›Paper›PMID 28981380›Full record

ArticleAutophagy2017

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.

Natalya Kaverina, Anton V Borovjagin, Zaira Kadagidze, Anatoly Baryshnikov, Maria Baryshnikova, Dmitry Malin, Dhimankrishhna Ghosh, Nameeta Shah, Danny R Welch, Patrik Gabikian and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. The role of microRNAs in brain metastasis.Journal of neuro-oncology · 2024
    Review
  8. Review
  9. Review
  10. The tumor-nerve circuit in breast cancer.Cancer metastasis reviews · 2023
    Review
  11. Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Natalya Kaverinaa Department of Tumor Immunology , Institute of Experimental Diagnostics and Therapy of Tumors, N.N. Blokhin Cancer Research Center , Moscow , Russia.
Anton V Borovjaginb University of Alabama at Birmingham School of Dentistry, Institute of Oral Health Research , Birmingham , AL , USA.
Zaira Kadagidzea Department of Tumor Immunology , Institute of Experimental Diagnostics and Therapy of Tumors, N.N. Blokhin Cancer Research Center , Moscow , Russia.ORCID 0000-0002-0058-0987
Anatoly Baryshnikovc Institute of Experimental Diagnostics and Therapy of Tumors, N.N. Blokhin Cancer Research Center , Moscow , Russia.ORCID 0000-0002-2442-3011
Maria Baryshnikovac Institute of Experimental Diagnostics and Therapy of Tumors, N.N. Blokhin Cancer Research Center , Moscow , Russia.
Dmitry Malind Department of Endocrinology , University of Wisconsin-Madison , Madison , WI , USA.ORCID 0000-0002-5728-7511
Dhimankrishhna Ghoshf Center for Advanced Brain Tumor Treatment , Swedish Neuroscience Institute , Seattle , WA , USA.
Nameeta Shahf Center for Advanced Brain Tumor Treatment , Swedish Neuroscience Institute , Seattle , WA , USA.
Danny R Welchg Department of Cancer Biology , Kansas University Medical Center (KUMC) , Kansas City , KS , USA.ORCID 0000-0002-1951-4947
Patrik Gabikianh Department of Neurosurgery , Kaiser Permanente Los Angeles Medical Center , Los Angeles , CA , USA.
Apollon Karseladzei Pathology , Institute of Experimental Diagnostics and Therapy of Tumors, N.N. Blokhin Cancer Research Center , Moscow , Russia.
Charles Cobbse Laboratory of Psychiatric Neurobiology , Institute of Molecular Medicine, Sechenov First Moscow State Medical University , Moscow , Russia.ORCID 0000-0001-7688-4293
Ilya V Ulasovf Center for Advanced Brain Tumor Treatment , Swedish Neuroscience Institute , Seattle , WA , USA.ORCID 0000-0002-0818-0363
Russian Cancer Research Center NN Blokhin · RUSechenov University · RUSwedish Medical Center · USKaiser Permanente · USUniversity Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Wisconsin–Madison · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
KISS1: Defining Mechanisms for Antimetastatic TherapyR01CA134981 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WELCH, DANNY R. · 2009 to 2014
$1.5M
NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA134981
6 · The paper itself

Abstract

Formation of metastases, also known as cancer dissemination, is an important stage of breast cancer (BrCa) development. KISS1 expression is associated with inhibition of metastases development. Recently we have demonstrated that BrCa metastases to the brain exhibit low levels of KISS1 expression at both mRNA and protein levels. By using multicolor immunofluorescence and coculture techniques here we show that normal adult astrocytes in the brain are capable of promoting metastatic transformation of circulating breast cancer cells localized to the brain through secretion of chemokine CXCL12. The latter was found in this study to downregulate KISS1 expression at the post-transcriptional level via induction of microRNA-345 (MIR345). Furthermore, we demonstrated that ectopic expression of KISS1 downregulates ATG5 and ATG7, 2 key modulators of autophagy, and works concurrently with autophagy inhibitors, thereby implicating autophagy in the mechanism of KISS1-mediated BrCa metastatic transformation. We also found that expression of KISS1 in human breast tumor specimens inversely correlates with that of MMP9 and IL8, implicated in the mechanism of metastatic invasion, thereby supporting the role of KISS1 as a potential regulator of BrCa metastatic invasion in the brain. This conclusion is further supported by the ability of KISS1, ectopically overexpressed from an adenoviral vector in MDA-MB-231Br cells with silenced expression of the endogenous gene, to revert invasive phenotype of those cells. Taken together, our results strongly suggest that human adult astrocytes can promote brain invasion of the brain-localized circulating breast cancer cells by upregulating autophagy signaling pathways via the CXCL12-MIR345- KISS1 axis.

Indexed as

AutophagyAdultAgedAnimalsAstrocytesAutophagy-Related Protein 5Autophagy-Related Protein 7Brain NeoplasmsBreast NeoplasmsCarcinoma, Ductal, BreastCell Line, TumorChemokine CXCL12FemaleHumansInterleukin-8KisspeptinsATG5 protein, humanATG7 protein, humanAutophagy-Related Protein 5Autophagy-Related Protein 7Chemokine CXCL12CXCL12 protein, humanCXCL8 protein, humanInterleukin-8KISS1 protein, humanKisspeptinsMatrix Metalloproteinase 9MicroRNAsMIRN345 microRNA, humanMMP9 protein, humanautophagybrain metastasesbreast cancerKISS1 suppressorstem cells

Identifiers

PMID28981380
PMCPMC5788498
OpenAlexW2763451882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.